Study #2017-0973
A prospective observational cohort study of indwelling pleural catheters versus indwelling pleural catheters plus doxycycline pleurodesis for treatment of malignant pleural effusions
MD Anderson Study Status
Enrolling
Treatment Agent
Doxycycline
Description
This study is designed to obtain preliminary data comparing indwelling pleural catheters (IPCs) versus IPCs plus doxycycline for pleurodesis as treatments for malignant pleural effusion (MPE). Indwelling pleural catheters (IPCs) are commonly used to treat pleural effusions (build-up of fluid in the lungs). Doxycycline is an antibiotic that is also used to treat pleural effusions. The goal of this clinical research study is to learn if adding doxycycline to the use of an IPC can lead to shorter treatment times with IPCs.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Pleural Neoplasm
Study phase:
Physician name:
David Ost
Department:
Pulmonary Medicine
For general questions about clinical trials:
1-855-922-5134
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.